Sangamo Therapeutics
SGMO
SGMO
196 hedge funds and large institutions have $477M invested in Sangamo Therapeutics in 2022 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 67 increasing their positions, 46 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
5% more funds holding
Funds holding: 187 → 196 (+9)
1.07% more ownership
Funds ownership: 61.13% → 62.2% (+1.1%)
Holders
196
Holding in Top 10
–
Calls
$2.45M
Puts
$1.97M
Top Buyers
| 1 | +$11.6M | |
| 2 | +$11.1M | |
| 3 | +$9.3M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.91M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$3.58M |
Top Sellers
| 1 | -$4.14M | |
| 2 | -$3.78M | |
| 3 | -$2.85M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$1.94M |
| 5 |
Morgan Stanley
New York
|
-$1.57M |